SAN DIEGO--(BUSINESS WIRE)--Nanogen, Inc. (Nasdaq:NGEN), developer of in vitro diagnostic products, today reported its unaudited financial results for the quarter ended June 30, 2008.
SAN DIEGO--(BUSINESS WIRE)--Nanogen, Inc. (Nasdaq:NGEN), developer of in vitro diagnostic products, today reported its unaudited financial results for the quarter ended June 30, 2008.